learn HMI-115
much-hyped research compound targeting prolactin receptor in scalp
Search
forCommunity Join
5 / 176 resultscommunity Is hmi 115 the cure? Or is it 🧢 just like cosmeRNA, brezula, pyrilutamide, and other 📞 ies
HMI 115 is being discussed as a potential hair loss treatment, with skepticism due to past disappointments like cosmeRNA, brezula, and pyrilutamide. The user is questioning if they should be hopeful for new developments in the next six years.
community HMI-115: What We Know So Far. HMI-115 (also known as BAY1158061) is a new pharmaceutical drug developed by a biopharmaceutical company called Bioinvent and licensed by Bayer
HMI-115 is a new drug developed by Bioinvent and licensed by Bayer, with mixed opinions on its potential effectiveness. Some users are skeptical and prefer proven treatments like Minoxidil, finasteride, and RU58841.
community 2-month HMI-115 results from the Chinese trial
HMI-115 shows promising hair growth and thickening in just 2 months. Results are positive but need more time for confirmation.
community HMI 115 Phase 2 - Leaked pics from Discord
The conversation discusses HMI 115, a new hair loss treatment with promising results, showing a significant increase in hair density after two months. Some users are skeptical, while others are hopeful for its release and potential affordability.
community HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
Chime Biologics and Hope Medicine are speeding up the launch of a first-in-class antibody drug, HMI-115, for endometriosis and androgenic alopecia. The treatment involves a series of subcutaneous injections, has shown promising results in phase 1, and continues to promote hair regrowth even after the treatment is stopped.
Research
5 / 68 resultsresearch The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
New and existing treatments for hair loss show promise, with some being more effective for men and others for women.
research A Study on the Effectiveness and Safety of Herbal Extract Combination Compared to 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A Randomized, Double-blind, Controlled Trial
The herbal extract is as effective and safe as 3% minoxidil for treating hair loss.
research Emerging pharmacotherapies for Androgenetic Alopecia
New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.
research A dietary supplement improves age-related dermatological changes. Observational, anecdotal, spontaneous study.
The dietary supplement significantly improved skin, nails, and hair in older adults.
research Topical application of the Wnt/β-catenin activator methyl vanillate increases hair count and hair mass index in women with androgenetic alopecia
Methyl vanillate spray increases hair count and hair mass in women with hair loss.
Clinics
6 / 12 results- 80
Hair TransplantHair Loss TreatmentsHM Clinic - Dr. Henrique Machado, Medicina e Transplantes CapilaresLisboa · PT - 34
Hair TransplantHair Loss TreatmentsSMPHM HaartransplantatieEindhoven · NL - 57Hair TransplantHair Loss TreatmentsHm-HairmedicalKöln, Nordrhein Westfalen · DE
- 47
Hair TransplantHair Loss TreatmentsMHW CosmeticsDagenham · GB - 24
SMPMM ScalpHenderson, NV · US - 88
SMPMM Seattle SMPSeattle, WA · US
Experts
6 / 20 results- 36
TrichologistMae Boyd
Meridian, MS, United States
- 76
Hair System SpecialistMo'Nika J
Dallas, TX, United States
- UnscoredSMP Specialist
Mai Kairak
Madison, United States
- 17
SMP SpecialistMai Duong
Mannheim, Baden Wurttemberg, Germany
- 23
Hair System SpecialistMei H G Turner
Telford, United Kingdom
- 80
Hair Transplant SurgeonDr. Mo Khairy Mosa, MD
Melbourne, VIC, Australia